drug launches

Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Flag link:
Bristol Myers Squibb's Zeposia launches into crowded MS market
Bristol Myers Squibb's Zeposia launches into crowded MS market
Fierce Pharma
Bristol-Myers Squibb
Celgene
Zeposia
drug launches
MS
multiple sclerosis
Flag link:
BioCryst Plans to Raise $100 Million
BioCryst Plans to Raise $100 Million
Motley Fool
drug launches
Biocryst
HAE
berotralstat
Flag link:
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
Flag link:
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Fierce Pharma
Immunomedics
drug launches
Trodelvy
triple-negative breast cancer
pandemic
COVID-19
Flag link:
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Biopharma Dive
Neurocrine
Parkinson's Disease
drug launches
COVID-19
pandemic
Flag link:
Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal
Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal
Fierce Pharma
JNJ
vaccines
COVID-19
drug launches
CMOs
Emergent BioSolutions
Flag link:
Covid-19 adds a new danger to drug launches
Covid-19 adds a new danger to drug launches
EP Vantage
drug launches
pandemic
COVID-19
Esperion
Biohaven
Urogen
Flag link:
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
Marketwatch
COVID-19
pandemic
clinical trials
drug launches
M&A
conferences
Flag link:
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch
Xconomy
Bristol-Meyers Squibb
Celgene
M&A
ozanimod
MS
mutliple sclerosis
drug launches
FDA
COVID-19
Zeposia
Flag link:
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Fierce Pharma
Biohaven
migraines
drug launches
digital pharma
COVID-19
pandemic
Nurtec
Flag link:
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing
Xconomy
Aimmune Therapeutics
Palforzia
drug launches
REMS
Jayson Dallas
drug manufacturing
Flag link:
Reyvow, Migraine Drug That Treats Pain In Hours, Now Hits The Shelves
Reyvow, Migraine Drug That Treats Pain In Hours, Now Hits The Shelves
Forbes
Reyvow
migraines
drug launches
Eli Lilly
Flag link:
Blockbusters in waiting: drug launches to watch in 2020
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
Flag link:
GBT takes a page from HIV playbook as it embarks on Oxbryta launch
GBT takes a page from HIV playbook as it embarks on Oxbryta launch
Fierce Pharma
Global Blood Therapeutics
drug launches
Oxbryta
sickle cell disease
HIV
Flag link:
Vertex impresses with strong Trikafta launch
Vertex impresses with strong Trikafta launch
BioPharma Dive
Vertex Pharmaceuticals
drug launches
cystic fibrosis
Trikafta
earnings
Flag link:
18% of Indian pharma launches to be delayed in US, says Crisil
18% of Indian pharma launches to be delayed in US, says Crisil
Economic Times, India
India
drug launches
FDA
Flag link:
JPM: New Novartis pharma chief rethinks its drug-launch formula
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Novartis
Pharma CEOs
Vas Narasimhan
drug launches
JPMHC 2020
Flag link:
5 biotech trends to follow in 2020
5 biotech trends to follow in 2020
BioPharma Dive
biotech
M&A
drug launches
JPMHC 2020
Flag link:
3 Blockbuster Cancer Drug Launches to Watch in 2020
3 Blockbuster Cancer Drug Launches to Watch in 2020
Motley Fool
FDA
drug approvals
cancer
drug launches
AstraZeneca
Enhertu
Padcev
Seattle Genetics
BeiGene
Brukinsa
Flag link:

Pages